Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Prilozi
|
August 25, 2005
The evolution of untreated borderline and subclinical rejections at first month kidney allograft biopsy in comparison with histological changes at 6 months protocol biopsies
J Masin-Spasovska, G Spasovski, S Dzikova, et al.
Prilozi
|
January 10, 2006
Chronic allograft nephropathy (CAN) in early renal protocol biopsies: does treatment of borderline and subclinical acute rejections prevent development and progression of CAN?
J Masin-Spasovska, G Spasovski, M Polenaković, et al.
World Journal of Urology
|
January 1, 1993
Prognostic factors in superficial bladder cancer
D K Chopin, Z Popov, V Ravery, et al.
Histopathology
|
December 1, 1994
Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparison with Ki-67 antibody
C Mazerolles, P Rishmann, D Chopin, et al.
Prilozi
|
January 10, 2006
Recurrent glomerulonephritis in living kidney transplantation
G Spasovski, N Ivanovski, J Masin-Spasovska, et al.
Prilozi
|
January 31, 2012
Evaluation of the value of p53 protein expression in the extra-capsular extension of prostate cancer
S Saidi, V Georgiev, S Stavridis, et al.
British Journal of Cancer
|
January 1, 1995
Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer
V Ravery, M Colombel, Z Popov, et al.
Oncogene
|
October 19, 1999
Relationship between E-cadherin and fibroblast growth factor receptor 2b expression in bladder carcinomas
S G De Medina, Z Popov, D K Chopin, et al.
Journal of Cardiac Surgery
|
October 16, 2012
Technical strategy in a patient with symptomatic thoracic aneurysm near the origin of the left subclavian artery and left internal thoracic artery coronary graft
Srdjan D Babic, Djordje J Radak, Vuk A Sotirovic, et al.
Cancer
|
October 24, 1997
The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder
Z Popov, A Hoznek, M Colombel, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Prilozi
|
August 25, 2005
The evolution of untreated borderline and subclinical rejections at first month kidney allograft biopsy in comparison with histological changes at 6 months protocol biopsies
J Masin-Spasovska, G Spasovski, S Dzikova, et al.
Prilozi
|
January 10, 2006
Chronic allograft nephropathy (CAN) in early renal protocol biopsies: does treatment of borderline and subclinical acute rejections prevent development and progression of CAN?
J Masin-Spasovska, G Spasovski, M Polenaković, et al.
World Journal of Urology
|
January 1, 1993
Prognostic factors in superficial bladder cancer
D K Chopin, Z Popov, V Ravery, et al.
Histopathology
|
December 1, 1994
Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparison with Ki-67 antibody
C Mazerolles, P Rishmann, D Chopin, et al.
Prilozi
|
January 10, 2006
Recurrent glomerulonephritis in living kidney transplantation
G Spasovski, N Ivanovski, J Masin-Spasovska, et al.
Prilozi
|
January 31, 2012
Evaluation of the value of p53 protein expression in the extra-capsular extension of prostate cancer
S Saidi, V Georgiev, S Stavridis, et al.
British Journal of Cancer
|
January 1, 1995
Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer
V Ravery, M Colombel, Z Popov, et al.
Oncogene
|
October 19, 1999
Relationship between E-cadherin and fibroblast growth factor receptor 2b expression in bladder carcinomas
S G De Medina, Z Popov, D K Chopin, et al.
Journal of Cardiac Surgery
|
October 16, 2012
Technical strategy in a patient with symptomatic thoracic aneurysm near the origin of the left subclavian artery and left internal thoracic artery coronary graft
Srdjan D Babic, Djordje J Radak, Vuk A Sotirovic, et al.
Cancer
|
October 24, 1997
The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder
Z Popov, A Hoznek, M Colombel, et al.
Page
of 6